News

Amid a surging COVID-19 pandemic, ophthalmologists in the path of Hurricane Ida are now dealing with the storm's impact.

Reports indicate the variant was first detected in Colombia in early 2021 and has currently spread to 39 countries including the United States.

Study examines immunomodulatory therapy as a potential long-term treatment option.

Organization looks to improve global eye care through ophthalmic education.

According to the Academy and RPB, the grant recipients will use the IRIS Registry database to improve the diagnosis and treatment of eye disease.

Investigators searched PubMed over the past 2 decades for clinical trials on eyelid ptosis using the terms blepharoptosis or upper eyelid ptosis or eyelid ptosis” and the filters “randomized controlled trial (RCT), clinical trial, and humans.”

Randomly assigned controlled trials key in increasing understanding of disease.

Check out the latest cartoon!

Corticosteroids and antibiotics may be indicated in patients with severe rhinosinusitis until either IgG4-related or bacterial rhinosinusitis can be ruled out.

Investigators examine usefulness in refractive surgery evaluations

A team of investigators at McMaster University in Toronto has found that fluvoxamine reduced hospitalizations by up to 30 percent.

In PIONEER study, investigators outline their successes.

Experts provide perspectives on current care and pipeline products.

A team of UK researchers further examine the rare thrombocytopenia and thromboembolic events occurring after COVID-19 vaccinations.

Symptomatic, psychosocial burdens in participants .

Led by eye care nonprofit Orbis with support from Alcon, the training will build eye care professionals' skills to treat retinopathy of prematurity in Latin America

Ian Han, MD, shares his thoughts in the latest guest editorial.

COO JD Schaub provides an overview of how RVL Pharmaceuticals has shifted toward becoming an ocular aesthetics company, with the sole purpose to fully focus on UPNEEQ®.

According to McKinsey’s Hospital Insights Survey, hospital outpatient and procedural volumes were nearly 4 percent higher in July compared to 2019, but ophthalmology was down during the same period.

Investigation evaluates safety of single and multiple intravitreal injections.

Regeneron Pharmaceuticals announced at an ongoing Phase 2 trial has met its primary safety endpoint with no new safety signals observed.

Researchers conducted a retrospective observational study to assess the corneal refractive changes induced by surgery to correct ptosis using Fourier harmonic analysis.

Sight Sciences reveals real-world data that show the safety, efficacy, and durability of effect of its Omni Surgical System for use in a standalone procedure to reduce IOP and medication burden.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

According to the company, its partnership will educate the gaming community on common dry eye symptoms and introduce over-the-counter options like its Systane brand of eye drops.

Advances help gain clearer image, enhancing decision-making process.

The approval could lead hospitals, universities, corporations and even local governents to enact vaccination mandates.

RightEye Sensorimotor is a new technology designed to greatly improve patient care and increase optometry and ophthalmology practice revenue.